KalVista CMO Disposes of $83,344 in Stock; Company Posts Strong EKTERLY Launch Figures
KalVista Pharmaceuticals Chief Medical Officer Paul K. Audhya sold 5,354 shares on February 23, 2026, generating about $83,344. The sale followed the exercise and conversion of 11,250 restricted stock units into common shares on February 21 and 22. KalVista's stock trades around $15.77, and the company reported preliminary global EKTERLY sales of r…